Elixxer Ltd. Grants Stock Options
17 January 2020 - 12:58AM
Elixxer Ltd. (the “
Corporation” or
“
Elixxer”) (TSX-V: ELXR and OTC-QB: ELXIF)
announces that it has granted stock options to purchase a total of
13,506,403 common shares of the Corporation to certain of its
senior officers and directors and stock options to purchase
1,500,000 common shares of the Corporation to a consultant.
All of the options are exercisable at a price of
$0.05 per share and have a term of five years.
The options are subject in all respects to the
terms of Elixxer’s stock option plan and the requirements of the
TSX Venture Exchange.
About Elixxer Ltd.
(www.elixxer.com)
Elixxer Ltd. is a leading cannabis investment
firm with a focus on the legal global cannabis market. Through its
growing portfolio of investment companies, ELXR is building a
transversal integrated organization of interconnected legal
cannabis companies with cultivation, processing and distribution in
Australia, Jamaica, Switzerland, Italy, and Canada serving domestic
and export markets. Elixxer Ltd. is a Canadian incorporated public
company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US
OTC-QB exchange (OTCQB: ELXIF).
For further information please
contact:
President, John McMullen, +1-416-803-0698,
john@elixxer.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Elixxer (TSXV:ELXR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Elixxer (TSXV:ELXR)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Elixxer Ltd (TSX Venture Exchange): 0 recent articles
More News Articles